PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.\', \'Current affiliation: Morehouse School of Medicine, Atlanta, Georgia, USA.\', \'Division of Gastroenterology, University of Mississippi Medical Center (UMMC), Jackson, Mississippi, USA.\', \'Department of Oral Immunology and Infectious Diseases, University of Louisville School of Dentistry, Louisville, Kentucky, USA.\', \'Division of Gastroenterology, Department of Medicine, University of Florida, Gainesville, Florida, USA.\', \'UMMC Center for Informatics and Analytics, Jackson, Mississippi, USA.\', \'Division of Pulmonary, Critical Care, and Sleep Medicine, UMMC, Jackson, Mississippi, USA.\', \'Department of Medicine, Brigham and Women\'s Hospital, Boston, Massachusetts, USA.\', \'Boston Children\'s Hospital, Boston, Massachusetts, USA.\', \'Department of Sociology, University at Buffalo, SUNY Buffalo, New York, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.14309/ajg.0000000000001311
?:hasPublicationType
?:journal
  • The American journal of gastroenterology
is ?:pmid of
?:pmid
?:pmid
  • 34047305
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all